Skip to main content

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.

Bai Y, Cheng H, Bordeaux J, Neumeister V, Kumar S, Rimm DL, Stern DF

Publication: PLoS One (2013) • Vol 8 • Page e79901PMID: 24278211View on PubMed

Purpose

The purpose of this paper was to determine the effects of tissue collection method and using the Autotmated Quantitative Analysis (AQUA) method for quantitative immunofluorescence versus standard immunohistochemical (IHC) staining on the detection of human epidermal growth factor receptor 2 (HER2) and phospho-HER2 in formalin-fixed, paraffin-embedded (FFPE) breast cancer specimens.

Conclusion

HER2 AQUA scores were consistent with standard manual IHC scoring results for both core needle biopsy (CNB) and resection specimens, but HER2 AQUA scores were significantly different between CNB and resection specimens, with lower scores in the resection than the CNB for 50 of 63 pairs. Further, there were significant differences in HER2 AQUA scores between CNB and resection specimens in each clinical group (negative, weakly positive, and strong positive). Similarly, 24/26 specimen pairs showed significantly lower pHER2 AQUA scores in the resection specimen than the CNB. There was no significant correlation between HER2 and pHER2 AQUA scores.

Studies (1)

Purpose

The purpose of this study was to determine the effects of tissue collection method (CNB versus resection) and using the AQUA method for quantitative immunofluorescence versus standard IHC staining for the detection of HER2 and pHER2 in FFPE breast cancer specimens. 67 pairs of specimens were included in the study. Cold ischemia times for resection specimens were unknown but assumed to be longer than those for biopsy specimens. 

Summary of Findings

HER2 AQUA scores were consistent with standard manual IHC scoring results for both CNB and resection specimens. The average HER2 AQUA score was significantly different between CNB and resection specimens (p<0.0001), with lower scores in the resection than the CNB for 50 of 63 pairs. Further, there were significant differences in HER2 AQUA scores between CNB and resection specimens in each clinical group (negative, weakly positive, and strong positive). Similarly, 24/26 specimen pairs showed significantly lower pHER2 AQUA scores in the resection specimen than the CNB. There was no significant correlation between HER2 and pHER2 AQUA scores.

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of tissue acquisition
    Core needle biopsy
    Surgical resection
    Immunohistochemistry SpecificData handling
    AQUA scoring
    Manual scoring
    Immunohistochemistry SpecificTargeted peptide/protein
    HER2
    pTyr1248-HER2